1Toruner M, Soykan I, Ensari A, et al. Barrett' s esophagus: Prevalence and its relationship with dyspeptic symptoms. J Gastroenterol Hepatol, 2004, 19: 535-540.
2Carmona-Sanchez R, Navarro-Cano G.Prevalence of hdicobacter pylori infection in patients with reflux esophagitis. A case-control study. Rev Gastroenterol Mex, 2003,68 : 23-28.
3Abbas AE, Deschamps C, Cassivi SD, et al.Barrett' s oesophagus: the role of laparoscopic fundoplication, Ann Thorac Surg,2004, 77:393-39 6.
4Brant KO, Marc B, Lilly C, et al. Clinical and pathologic response of Barrett' soesophagus tolaparoscopic antireflux surgery. AnnSurg, 2003, 238:458-466.
5Ei-Serag HB, Garewel H, Kuebler M, et al.Is the length of newly diagnosed Barrett's esophagus decreasing? The experience of aVA health care system. Clin GaztroenterolHepatol, 2004, 2 : 296-300.
6Hamamoto Y, Endo T, Nosho K, et al. Usefulness of narrow-band imaging endoscopy for diagnosis of Barrett' s esophagus. J Gastroenterol, 2004, 39 : 14-20.
7Fahmy M, Skacel M, Gramlich TL, et al.Chromosomal gains and genomic loss of p53 and p16 genes in Barrett's esophagus detected by fluorescence in situ hybridization of cytology specimens. Mod Pathol, 2004,17 : 588-596.
8Csendes A. Surgical treatment of Barrett' s esophagus. World J Surg, 2004, 28: 225-231.
9Hur C, Nishioka NS, Gazelle GS. Cost-effectiveness of aspirin chemoprevention for Barrett' s oesophagus. J Natl Cancer Inst,2004, 96:316-325.
10Parrilla P, Martinez LF, Ortiz A, et al.Long-term results of randomized prospective study comparing medical and surgical treatment of Barrett's esophagus. Ann Surg,2003, 237 : 291-298.
9Colin Jones DG.The role and limitations of H2-antagonists in treatment of gastro-esophagealre flux disease[J].Aliment Pharamcol Ther,1995,9(Suppl1):9-14
10Achem SR.Endoscopy-negative gastresophageal refluxdisease.The hypersensitive esophag us[J].Gastroenterol Clin of North Am,1999(28):893-904
